Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Cost of Revenue: 2011-2025

Historic Cost of Revenue for Abeona Therapeutics (ABEO) over the last 3 years, with Sep 2025 value amounting to $488,000.

  • Abeona Therapeutics' Cost of Revenue was N/A to $488,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $33.5 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2023, which is 256.67% up from last year.
  • As of Q3 2025, Abeona Therapeutics' Cost of Revenue stood at $488,000, which was up 1,526.67% from $30,000 recorded in Q3 2023.
  • Abeona Therapeutics' 5-year Cost of Revenue high stood at $32.9 million for Q1 2021, and its period low was $30,000 during Q3 2023.
  • For the 2-year period, Abeona Therapeutics' Cost of Revenue averaged around $259,000, with its median value being $259,000 (2023).